drugset / Trial / NCT01164774

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions

NCT01164774

Phase 1 Completed 54 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is * To characterize the pharmacokinetic profile of the Ramipril 10 mg capsules relative to that of ALTACE@ 10 mg capsules in healthy, adult, human, male subjects under non-fasting conditions and to assess the bioequivalence. * To monitor the safety of the subjects.

Timeline

Start
2005-10
Primary completion
2005-10
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramipril Small molecule 10 mg

Indications

No indication recorded.